ZNF275
gene geneOn this page
Summary
ZNF275 (zinc finger protein 275, HGNC:13069) is a protein-coding gene on chromosome Xq28, encoding Zinc finger protein 275 (Q9NSD4). May be involved in transcriptional regulation.
This gene encodes a zinc finger protein that appears to be conserved in eutheria. Its function has not yet been established.
Source: NCBI Gene 10838 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 82 total
- MANE Select transcript:
NM_001367757
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13069 |
| Approved symbol | ZNF275 |
| Name | zinc finger protein 275 |
| Location | Xq28 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000063587 |
| Ensembl biotype | protein_coding |
| Entrez | 10838 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 3 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000370249, ENST00000370251, ENST00000438239, ENST00000647705, ENST00000650114
RefSeq mRNA: 2 — MANE Select: NM_001367757
NM_001080485, NM_001367757
CCDS: CCDS48188, CCDS94693
Canonical transcript exons
ENST00000650114 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000000175 | 153334153 | 153334285 |
| ENSE00000869198 | 153345520 | 153345621 |
| ENSE00001452162 | 153336634 | 153336710 |
| ENSE00003832331 | 153346819 | 153352926 |
Expression profiles
Bgee: expression breadth ubiquitous, 243 present calls, max score 95.17.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.6714 / max 327.3902, expressed in 1747 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 198031 | 8.3549 | 1728 |
| 198030 | 0.6431 | 409 |
| 198032 | 0.3513 | 153 |
| 198033 | 0.3221 | 153 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adrenal cortex | UBERON:0001235 | 95.17 | gold quality |
| right adrenal gland | UBERON:0001233 | 95.08 | gold quality |
| left adrenal gland | UBERON:0001234 | 95.06 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 94.89 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 94.86 | gold quality |
| adrenal gland | UBERON:0002369 | 94.73 | gold quality |
| adrenal tissue | UBERON:0018303 | 93.70 | gold quality |
| tibia | UBERON:0000979 | 92.72 | gold quality |
| ileal mucosa | UBERON:0000331 | 92.31 | gold quality |
| tibialis anterior | UBERON:0001385 | 92.15 | silver quality |
| pancreatic ductal cell | CL:0002079 | 90.76 | silver quality |
| seminal vesicle | UBERON:0000998 | 89.92 | gold quality |
| visceral pleura | UBERON:0002401 | 89.40 | gold quality |
| corpus epididymis | UBERON:0004359 | 89.13 | gold quality |
| cartilage tissue | UBERON:0002418 | 88.96 | gold quality |
| parietal pleura | UBERON:0002400 | 88.73 | gold quality |
| caput epididymis | UBERON:0004358 | 88.70 | gold quality |
| left ovary | UBERON:0002119 | 87.71 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 87.70 | gold quality |
| ovary | UBERON:0000992 | 87.01 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 86.83 | silver quality |
| cauda epididymis | UBERON:0004360 | 86.57 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 86.45 | gold quality |
| deltoid | UBERON:0001476 | 86.26 | silver quality |
| right ovary | UBERON:0002118 | 86.14 | gold quality |
| medial globus pallidus | UBERON:0002477 | 85.68 | gold quality |
| adult organism | UBERON:0007023 | 85.40 | gold quality |
| globus pallidus | UBERON:0001875 | 84.16 | gold quality |
| postcentral gyrus | UBERON:0002581 | 83.96 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 83.53 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2550.1 | ZNF275 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605530
miRNA regulators (miRDB)
261 targeting ZNF275, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-518D-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-518E-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-518F-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-519A-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519B-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519C-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-520C-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-522-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-523-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-526A-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-6740-5P | 100.00 | 65.64 | 932 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:ch211-207i20.2 | ENSDARG00000099986 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631), ZNF3 (ENSG00000166526)
Protein
Protein identifiers
Zinc finger protein 275 — Q9NSD4 (reviewed: Q9NSD4)
All UniProt accessions (2): Q9NSD4, A6NFS0
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NSD4-1 | 1 | yes |
| Q9NSD4-2 | 2 |
RefSeq proteins (2): NP_001073954, NP_001354686* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050758 | Znf_C2H2-type | Family |
Pfam: PF00096
UniProt features (19 total): zinc finger region 11, compositionally biased region 3, region of interest 2, chain 1, modified residue 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NSD4-F1 | 72.83 | 0.22 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 76
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 100 (showing top):
GCM_MAP4K4, BILD_E2F3_ONCOGENIC_SIGNATURE, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5, FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN, GCM_NF2, GCM_CALM1, OSMAN_BLADDER_CANCER_DN, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, GCM_BMPR2, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, WONG_ADULT_TISSUE_STEM_MODULE, GCM_RAN, chrXq28, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MIER1_TARGET_GENES
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
394 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF275 | ATP1B4 | Q9UN42 | 523 |
| ZNF275 | PIP4K2C | Q8TBX8 | 472 |
| ZNF275 | TEX28 | O15482 | 400 |
| ZNF275 | RNF133 | Q8WVZ7 | 396 |
| ZNF275 | SPTY2D1 | Q68D10 | 393 |
| ZNF275 | MSANTD3 | Q96H12 | 393 |
| ZNF275 | WDR44 | Q5JSH3 | 368 |
| ZNF275 | RNASE8 | Q8TDE3 | 366 |
| ZNF275 | PRR12 | Q9ULL5 | 362 |
| ZNF275 | MAP7D3 | Q8IWC1 | 350 |
| ZNF275 | SH3GL2 | Q99962 | 349 |
| ZNF275 | PUSL1 | Q8N0Z8 | 348 |
| ZNF275 | DNAJC5G | Q8N7S2 | 329 |
| ZNF275 | DRC5 | Q5JU00 | 328 |
| ZNF275 | NHSL1 | Q5SYE7 | 323 |
IntAct
38 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF648 | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-9 | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM41 | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LIN28A | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF837 | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM10 | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAF4 | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BAHD1 | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF792 | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF329 | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF4 | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CNBP | NOP56 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF648 | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF275 | KRTAP10-9 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF275 | TRIM41 | psi-mi:“MI:0915”(physical association) | 0.000 |
| LIN28A | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF837 | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RBM10 | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TRAF4 | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TRIM41 | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.000 |
| BAHD1 | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF792 | ZNF275 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF275 | RNF4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF275 | ZNF329 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (27): ZNF275 (Affinity Capture-MS), ZNF275 (Affinity Capture-MS), ZNF275 (Affinity Capture-RNA), RNF4 (Two-hybrid), TRAF4 (Two-hybrid), LIN28A (Two-hybrid), BAHD1 (Two-hybrid), TRIM41 (Two-hybrid), ZNF837 (Two-hybrid), ZNF648 (Two-hybrid), ZNF792 (Two-hybrid), ZNF329 (Two-hybrid), RBM10 (Two-hybrid), KRTAP10-9 (Two-hybrid), ZNF275 (Affinity Capture-MS)
ESM2 similar proteins: A3KN32, A6NM28, A8K8V0, E9PYI1, O75467, O95201, P10072, P10075, P10078, P10754, P28698, P30373, P52736, Q0VCC5, Q14929, Q16587, Q17QR7, Q29RZ4, Q3KNW1, Q3TDE8, Q3US17, Q58DK7, Q5RJR4, Q5T619, Q5TEC3, Q5U4E2, Q62396, Q68H95, Q6AW86, Q6PGE4, Q6ZMY9, Q7Z398, Q7Z7K2, Q8BI73, Q8BIF9, Q8BIQ3, Q8BKK5, Q8JZL0, Q8N393, Q8R0T2
Diamond homologs: A6QR00, P0CG23, P18735, Q569E7, Q5TEC3, Q6H236, Q6ZNH5, Q8BI66, Q8NF99, Q8TF50, Q96EG3, Q9H7R5, Q9NSD4, Q7Z7K2, Q8BI67, Q8BI73, Q3US17, Q5EBL2, Q6DD87, Q8BI69, Q8BIF9, Q8BIQ3, Q8CJ78, Q8NCA9, Q8TBZ5, Q96BV0, Q96MX3, Q9H4T2, A1L2U9, B1WAZ8, B1WBU4, E9PZZ1, O14258, O75362, P39770, P39806, P78978, P80944, Q09838, Q0IH98
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
82 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 30 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
397 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:153345519:GGC:G | acceptor_gain | 1.0000 |
| X:153345619:CTGG:C | donor_loss | 1.0000 |
| X:153344420:C:G | donor_gain | 0.9900 |
| X:153344437:A:T | donor_gain | 0.9900 |
| X:153344785:G:GT | donor_gain | 0.9900 |
| X:153345513:T:G | acceptor_gain | 0.9900 |
| X:153345518:A:AG | acceptor_gain | 0.9900 |
| X:153345519:G:GG | acceptor_gain | 0.9900 |
| X:153345610:C:G | donor_gain | 0.9900 |
| X:153345622:G:GG | donor_gain | 0.9900 |
| X:153345624:G:GC | donor_loss | 0.9900 |
| X:153346816:CAG:C | acceptor_loss | 0.9900 |
| X:153346817:A:AC | acceptor_loss | 0.9900 |
| X:153346817:A:AG | acceptor_gain | 0.9900 |
| X:153346818:G:GA | acceptor_gain | 0.9900 |
| X:153346818:G:GT | acceptor_loss | 0.9900 |
| X:153346818:GAAA:G | acceptor_gain | 0.9900 |
| X:153344775:TGTGG:T | donor_loss | 0.9800 |
| X:153344776:GTGG:G | donor_gain | 0.9800 |
| X:153344778:GG:G | donor_gain | 0.9800 |
| X:153344779:GG:G | donor_gain | 0.9800 |
| X:153344780:GT:G | donor_loss | 0.9800 |
| X:153344781:T:TC | donor_loss | 0.9800 |
| X:153345512:A:AG | acceptor_gain | 0.9800 |
| X:153345514:GAGCA:G | acceptor_loss | 0.9800 |
| X:153345609:GC:G | donor_gain | 0.9800 |
| X:153346811:C:CA | acceptor_gain | 0.9800 |
| X:153346818:GA:G | acceptor_gain | 0.9800 |
| X:153346818:GAA:G | acceptor_gain | 0.9800 |
| X:153344764:A:T | donor_gain | 0.9700 |
AlphaMissense
2862 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:153347337:T:C | F218L | 0.999 |
| X:153347339:C:A | F218L | 0.999 |
| X:153347339:C:G | F218L | 0.999 |
| X:153347505:T:C | F274L | 0.999 |
| X:153347507:C:A | F274L | 0.999 |
| X:153347507:C:G | F274L | 0.999 |
| X:153347589:T:C | F302L | 0.999 |
| X:153347591:C:A | F302L | 0.999 |
| X:153347591:C:G | F302L | 0.999 |
| X:153347608:T:C | L308P | 0.999 |
| X:153347673:T:C | F330L | 0.999 |
| X:153347675:C:A | F330L | 0.999 |
| X:153347675:C:G | F330L | 0.999 |
| X:153347757:T:C | F358L | 0.999 |
| X:153347759:C:A | F358L | 0.999 |
| X:153347759:C:G | F358L | 0.999 |
| X:153347841:T:C | F386L | 0.999 |
| X:153347843:C:A | F386L | 0.999 |
| X:153347843:C:G | F386L | 0.999 |
| X:153347282:T:A | H199Q | 0.998 |
| X:153347282:T:G | H199Q | 0.998 |
| X:153347356:T:C | L224P | 0.998 |
| X:153347421:T:C | F246L | 0.998 |
| X:153347423:C:A | F246L | 0.998 |
| X:153347423:C:G | F246L | 0.998 |
| X:153347440:T:C | L252P | 0.998 |
| X:153347450:C:A | H255Q | 0.998 |
| X:153347450:C:G | H255Q | 0.998 |
| X:153347506:T:C | F274S | 0.998 |
| X:153347534:C:A | H283Q | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000474864 (X:153343204 G>C), RS1000527425 (X:153343517 T>C), RS1000687346 (X:153334423 G>A), RS1000769373 (X:153351848 G>A), RS1001568772 (X:153352649 A>G), RS1001654031 (X:153344150 C>T), RS1001664123 (X:153344432 C>T), RS1001861611 (X:153334965 G>A,C), RS1002953823 (X:153339656 T>C), RS1003329620 (X:153345963 G>A), RS1003339815 (X:153346561 A>G), RS1003586492 (X:153337639 G>A), RS1003816184 (X:153335941 C>T), RS1004479348 (X:153350949 C>T), RS1004710637 (X:153343035 A>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Estradiol | increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| dicrotophos | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sulforaphane | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| beta-methylcholine | affects expression | 1 |
| abrine | decreases expression | 1 |
| PCI 5002 | affects cotreatment, increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Vehicle Emissions | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Cisplatin | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Lead | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Zinc | affects cotreatment, increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.